Understanding heart muscle response to high blood pressure
Official title: Response of the Myocardium to Hypertrophic Conditions in the Adult Population
Run by National Heart Centre Singapore · NCT02670031 · Data updated 2026-11-12
This study looks at how high blood pressure affects the heart muscle in people with hypertension to see if certain heart changes can help improve treatment strategies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years to 99 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | National Heart Centre Singapore Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | January 2016 |
| Main results expected | September 2031 |
| Study ends | September 2031 |
| Registry record updated | August 2, 2023 |
| Trial ID | NCT02670031 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 21 and over with physician-diagnosed essential hypertension who are either newly diagnosed or have resistant hypertension.
✕Probably not a fit
Patients with known secondary hypertension or contraindications to cardiovascular magnetic resonance will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the effects of hypertension on the heart muscle, specifically focusing on left ventricular hypertrophy and myocardial fibrosis. Utilizing advanced cardiovascular magnetic resonance imaging and high-sensitivity cardiac troponin blood assays, the study aims to assess the significance of myocardial fibrosis in a large cohort of 2000 patients with hypertension. Participants will undergo follow-up assessments over at least one year to monitor changes and outcomes related to their heart health. The findings could provide insights into better management strategies for hypertensive heart disease.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of hypertensive heart disease, potentially reducing the risk of heart failure in patients.
How similar studies have gone: While this study employs advanced imaging techniques, similar studies have shown varying degrees of success in understanding hypertensive heart disease, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 21 years and over 2. Physician diagnosed essential hypertension, on at least 1 medication for blood pressure control 3. Newly diagnosed hypertension: systolic blood pressure 140mmHg or greater (diastolic blood pressure 90mmHg or greater) on at least 2 office visits (Weber 2013) and not started on any anti hypertensive medications at time of ambulatory blood pressure monitoring 4. Resistant hypertension: persistent systolic blood pressure 140mmHg or greater (diastolic blood pressure 90mmHg or greater) despite on at least 3 anti-hypertensive medications (Jennings 2013; Weber 2013) Exclusion Criteria: 1. Known secondary hypertension: renal causes (renal artery stenosis, chronic renal failure); endocrine causes (aldosterone excess, pheochromocytoma, cushing's syndrome, hyperthyroidism); cardiac causes (coarctation of the aorta) 2. Contraindications to cardiovascular magnetic resonance: implantable devices, cerebral aneurysm clips, cochlear implants, renal impairment (GRF \<30ml/min/1.73m2), claustrophobia and women who are pregnant or breast-feeding 3. Limited life expectancy 4. On-going unstable medical conditions: hypertensive crisis, acute coronary syndromes or acute heart failure 5. History of coronary artery disease, ischemic heart disease 6. History of transient ischemic attacks or cerebrovascular events 7. History of atrial fibrillation 8. History of heart failure
Where it's running
-
National Heart Centre Singapore
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Calvin WL Chin, MBBS, PhD — National Heart Centre Singapore
- Study coordinator: Mu Jie Liew
- Email: liew.mu.jie@nhcs.com.sg
- Phone: 82002052
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Effects of a mineralocorticoid receptor antagonist on heart function in hypertensive patients
This study is testing if a heart medication called eplerenone can improve heart function better than another medication in people with high blood pressure and thickened heart muscles.
-
Understanding pediatric hypertension and its effects on the body
This study looks at how different factors related to blood pressure affect children aged 7-18 who have just been diagnosed with high blood pressure, to see how it impacts their health over two years.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.